Skip to content

Clinical trials

Pulmonary Disease, Chronic Obstructive trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Country / region: Spain Clear all

298 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20036
20045
20057
200611
200711
200811
200916
201015
201123
201219
201320
201415
201512
201613
201714
201812
201914
20208
20218
20229
202311
202412
202518
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed203
Unknown status52
Recruiting19
Terminated11
Not yet recruiting6
Active, not recruiting4
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca35
GlaxoSmithKline31
Novartis Pharmaceuticals23
Boehringer Ingelheim21
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau11
Universidad de Granada11
Novartis9
Sanofi7
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina5
Cimera4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive298
Lung Diseases18
Emphysema17
Asthma13
Bronchitis, Chronic11
Diabetes Mellitus8
Heart Failure8
Dyspnea6
Lung Diseases, Obstructive6
Hypertension4

Trials

Showing 1 to 25 of 298. Each trial links to its page on Pharma Observatory.

198 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.